Actuate Therapeutics Inc (ACTU) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ACTU Annual Balance Sheets →
Tracking balance sheet results across Actuate Therapeutics Inc to Jun 30 2025 helps illustrate how Jun 30 2026's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent4.43
Cash & Short-term Investments4.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.32
Total Current Assets4.75
Other Assets, Noncurrent0.45
Total Assets5.20
Liabilities
Accounts Payable, Current AC1.08
Accrued Liabilities, Current2.73
Other Liabilities, Current0.00
Total Current Liabilities3.81
Total Long-term Debt0.00
Other liabilities, Noncurrent0.40
Interest Payable Noncurrent-
License Payable Noncurrent0.40
Total Liabilities4.21
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock166.09
Retained Earnings / Accumulated Deficit-165.10
Other Equity0.00
Common Stockholder's Equity0.99
Total Stockholder's Equity0.99
Liabilities & Stockholder's Equity5.20
4 historic quarters locked

Sign in to unlock the full Actuate Therapeutics Inc balance sheet history.

About Actuate Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-006472

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.